Drawing for ZYNTEMA

USPTO serial 79213742

ZYNTEMA

Reviewed by CopyMark Law Group

Reg. 5494573Status 404
Filing date
Status date
Registration date
Jun 19, 2018
Examiner
HOFFMAN, DAVID AARON
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZYNTEMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma, all of the foregoing excluding pharmaceutical preparations and substances for the treatment or management of sleep disorders"SECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 16, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Jan 16, 2021DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 21, 2018FINPFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 17, 2018GPNXNOTIFICATION PROCESSED BY IB—
Jul 24, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 24, 2018FIMPFINAL DISPOSITION PROCESSED—
Jul 19, 2018GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Jun 19, 2018R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 14, 2018ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
May 9, 2018CHPBPOST PUBLICATION AMENDMENT - ENTERED—
May 7, 2018APETASSIGNED TO PETITION STAFF—
Apr 23, 2018EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Nov 30, 2017ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 31, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 11, 2017NPUBNOTICE OF PUBLICATION—
Sep 15, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 14, 2017DOCKASSIGNED TO EXAMINER—
Aug 23, 2017UNDNUNDELIVERABLE MAIL - NO ACTION TAKEN—
Aug 11, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 7, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 4, 2017LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Aug 3, 2017SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance